Terms: = Ovarian cancer AND CD79B, ENSG00000007312, 974, P40259, IGB, B29 AND Prognosis
4 results:
1. CD8 + T cell infiltration is associated with improved survival and negatively correlates with hypoxia in clear cell ovarian cancer.
Guo N; Yang A; Farooq FB; Kalaria S; Moss E; DeVorkin L; Lesperance M; Bénard F; Wilson D; Tinker AV; Nathoo FS; Hamilton PT; Lum JJ
Sci Rep; 2023 Apr; 13(1):6530. PubMed ID: 37085560
[TBL] [Abstract] [Full Text] [Related]
2. Impact of health-related quality of life (HRQoL) on short-term mortality in patients with recurrent ovarian, fallopian or peritoneal carcinoma (the NOGGO-AGO QoL prognosis-Score-Study): results of a meta-analysis in 2209 patients.
Armbrust R; Richter R; Woopen H; Hilpert F; Harter P; Sehouli J
ESMO Open; 2021 Apr; 6(2):100081. PubMed ID: 33743329
[TBL] [Abstract] [Full Text] [Related]
3. Metallothioneins may be a potential prognostic biomarker for tumors: A Prisma-compliant meta-analysis.
Wang L; Xin F; Lin N; Wang Y; Liu X; Liu J
Medicine (Baltimore); 2018 Dec; 97(52):e13786. PubMed ID: 30593161
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of the prognosis and recurrence of apparent early-stage ovarian tumors treated with laparoscopy and laparotomy: a meta-analysis of clinical studies.
Zhang Y; Fan S; Xiang Y; Duan H; Sun L
BMC Cancer; 2015 Aug; 15():597. PubMed ID: 26307038
[TBL] [Abstract] [Full Text] [Related]
